EU Approves Novel Food: 3'-Sialyllactose Sodium Salt for Market Release

In a recent development, the European Union (EU) has granted approval for a new type of food to enter the market. The EU Commission issued Regulation (EU) 2024/1047 on April 10, 2024, under Regulation (EC) No 2015/2283 of the European Parliament and of the Council. This regulation approves the use of 3'-Sialyllactose Sodium Salt as a novel food and amends Annex of EU Commission Implementing Regulation (EU) 2017/2470.

Details of EU Approval:

According to the EU Official Journal, the EU Commission has officially authorized the introduction of 3'-Sialyllactose Sodium Salt as a novel food. This approval comes in line with the regulations set forth by the European Parliament and the Council. The decision to approve this new food product was made in accordance with Regulation (EC) No 2015/2283.

3'-Sialyllactose Sodium Salt and its Production:

The approved 3'-Sialyllactose Sodium Salt is derived from a strain of Escherichia coli W (ATCC 9637). This strain has been specifically selected for the production of this novel food ingredient. The regulatory approval signifies that 3'-Sialyllactose Sodium Salt meets the necessary safety and quality standards required for market release.

Effective Date and Implications:

The regulation will come into effect twenty days after its publication. Following this, manufacturers and distributors will be able to introduce products containing 3'-Sialyllactose Sodium Salt into the EU market. This approval opens up new possibilities for food innovation and diversification within the industry.

The EU's approval of 3'-Sialyllactose Sodium Salt as a novel food marks an important milestone in the food industry. This decision highlights the EU's commitment to fostering innovation and ensuring the safety of novel food products. With this regulatory milestone, stakeholders in the food industry can explore the potential applications of 3'-Sialyllactose Sodium Salt and introduce innovative food offerings to consumers.